Freshpet (FRPT) Q3 2025 earnings summary

Executive summary

• Net sales grew 14% year-over-year in Q3 2025 to $288.8 million, driven by 12.9% volume gains and 1.1% favorable price/mix, with continued expansion in digital, e-commerce, and retail channels.

• Achieved positive free cash flow in Q3, now expecting to be free cash flow positive for the full year 2025, a year ahead of the original target.

• Net income surged to $101.7 million, up from $11.9 million, primarily due to a $77.9 million deferred tax benefit from the release of a valuation allowance.

• Adjusted EBITDA increased to $54.6 million, up 25% year-over-year, with margin improving to 18.9%.

• Adapted commercial strategy to address economic uncertainty, focusing on household penetration, MVP consumer segment, digital expansion, and operational efficiency.

Financial highlights

• Q3 2025 net sales were $288.8 million, up 14% year-over-year, primarily driven by volume.

• Adjusted gross margin was 46.0% (down from 46.5% prior year); GAAP gross margin was 39.5%.

• Adjusted EBITDA was $54.6 million, up from $43.5 million year-over-year.

• Net income was $101.7 million, up from $11.9 million, mainly due to a $77.9 million deferred tax benefit.

• Operating cash flow was $66.8 million, with $274.6 million cash on hand at quarter-end.

Outlook and guidance

• FY2025 net sales growth expected at approximately 13%, at the lower end of previous guidance.

• Adjusted EBITDA guidance narrowed to $190–$195 million.

• Capital expenditures for 2025 expected to be ~$140 million, reduced from ~$175 million.

• Expects to be free cash flow positive for full year 2025.

• Confident in achieving 48% adjusted gross margin and 22% adjusted EBITDA margin by 2027 if sales growth is at least low teens.